Development of UV Spectrophotometric Method and Estimation of Simvastatin in Tablet Formulation
Abstract
A simple, precise, accurate, and cost-effective UV–visible spectrophotometric method for simvastatin was developed and validated in accordance with ICH Q2 (R1) guidelines. The maximum absorbance wavelength (λmax) of simvastatin was determined to be 238 nm. The range of the calibration curve was between 1-20 µg/mL, and absorbance values were recorded at 238 nm to generate a calibration curve, yielding a correlation coefficient of 0.999. The calculated limit of detection (LOD) and limit of quantitation (LOQ) were 0.11406 µg/mL and 0.34565 µg/mL, respectively. The method demonstrated acceptable accuracy, precision, robustness, and ruggedness when evaluated with quality control standards. This validated method is suitable for the estimation of simvastatin in bulk drug and plant extract samples. The method demonstrated acceptable accuracy, precision, robustness, and ruggedness when evaluated with quality control standards. It was successfully applied for the estimation of simvastatin in bulk drug and commercial tablet formulations.
Keywords: UV-method, Simvastatin, Zocor, Tablet Estimation, Validation.
Keywords:
UV-method , Simvastatin, Zocor , Tablet Estimation , UV-method, Simvastatin, Zocor, Tablet Estimation, Validation. , Validation.DOI
https://doi.org/10.22270/jddt.v16i1.7444References
1. Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(5):484 93. https://doi.org/10.2183/pjab.86.484 PMid:20467214 PMCid:PMC3108295
2. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG CoA reductase. Science. 2001;292(5519):1160 4. https://doi.org/10.1126/science.1059344 PMid:11349148
3. Plosker GL, McTavish D. Simvastatin: a review of its pharmacology and therapeutic potential in hypercholesterolaemia. Drugs. 1991;42(1):65 89. https://doi.org/10.2165/00003495-199142010-00005 PMid:1718686
4. U.S. National Library of Medicine. Simvastatin [Internet]. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Aug 12]. Available from:
5. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074 82. https://doi.org/10.1093/nar/gkx1037 PMid:29126136 PMCid:PMC5753335
6. Sweetman SC, editor. Martindale: The complete drug reference. 37th ed. London: Pharmaceutical Press; 2011.
7. Guzik L, Mrozik W, Kamysz W. Determination of Simvastatin in Pharmaceutical Dosage Forms by Optimized and Validated Method Using HPLC/UV. Croat Chem Acta. 2010;83(4):371-7.
8. Desai MM, Pratima A, Nikalje G. Quality-by-Design Based Development and Validation of Stability Indicating Method by UPLC Method for Impurities of Simvastatin from Drug and Pharmaceutical Dosage Form [Internet]. Vol. 110, Indian Journal of Pharmaceutical Sciences. Available from: www.ijpsonline.com
9. Rajput G, Singh S, Das Kurmi B. Simultaneous estimation of simvastatin and fenofibrate from their combined dosage form by ultraviolet-visible spectroscopy using simultaneous equation method. Pharmaspire [Internet]. 2021;13(1):117-21. Available from: www.isfcppharmaspire.com
10. Dhobale G, Kanawade S, Hande R, Dhobale S, Tare H. Analytical Method Development by Using UV-Spectrophotometer for Estimation of Valsartan in Bulk. INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE. 2024 Jun 25;15(02):854-60. https://doi.org/10.25258/ijpqa.15.2.49
11. Jemal M, Ouyang Z, Powell ML. Direct-injection LC-MS-MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma [Internet]. Vol. 23, Journal of Pharmaceutical and Biomedical Analysis. 2000. Available from: www.elsevier.com/locate/jpba https://doi.org/10.1016/S0731-7085(00)00309-5 PMid:10933525
12. Sai Bharath R, Aswini A, Arshiya J, Nikhil Yadav J, Siddartha G, Richards OTRI PM, et al. Development and Validation of UV/Visible Spectrophotometric Method for the Estimation of Simavastatin in Bulk and Pharmaceutical Formulations. Int J Pharm [Internet]. 2017;7(2):138-41. Available from: http://www.pharmascholars.com
13. Maleque M, Hasan MR, Hossen F, Safi S. Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations. J Pharm Anal. 2012;2(6):454-7. https://doi.org/10.1016/j.jpha.2012.06.004 PMid:29403782 PMCid:PMC5760935
14. Sahoo NK, Sahu M, Srinivasa Rao P, Vineela RS, Indira Devi JNV, Sandhya Rani N, et al. Validation of assay indicating method development of simvastatin in bulk and its tablet dosage form by RP-HPLC. J Appl Pharm Sci. 2014;4(1):117-22. https://doi.org/10.7324/JAPS.2014.40120
15. Chavhan V, Reddy K, Ahhirao K. DEVELOPMENT OF UV SPECTROPHOTOMETRIC METHODS AND VALIDATION FOR ESTIMATION OF SIMVASTATIN IN BULK AND TABLET DOSAGE FORM BY ABSORBANCE MAXIMA AND AREA UNDER THE CURVE METHOD. Vol. 55, Journal of Applied Pharmacy. 2014. https://doi.org/10.21065/19204159.6.55
16. Munir A, Ahmad M, Malik MZ, Minhas MU. Analysis of simvastatin using a simple and fast high performance liquid chromatography-ultra violet method: Development, validation and application in solubility studies. Tropical Journal of Pharmaceutical Research. 2014 Jan;13(1):135-9. https://doi.org/10.4314/tjpr.v13i1.19
17. Sai Bharath R, Aswini A, Arshiya J, Nikhil Yadav J, Siddartha G, Richards OTRI PM, et al. Development and Validation of UV/Visible Spectrophotometric Method for the Estimation of Simavastatin in Bulk and Pharmaceutical Formulations. Int J Pharm [Internet]. 2017;7(2):138-41. Available from: http://www.pharmascholars.com
18. Birari AE. Development and Validation of UV-Spectrophotometric Method for Estimation of Simvastatin in Bulk and Solid Dosage Form.
19. Wang L, Asgharnejad M. Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form [Internet]. Vol. 21, Journal of Pharmaceutical and Biomedical Analysis. 2000. Available from: www.elsevier.com/locate/jpba https://doi.org/10.1016/S0731-7085(99)00231-9 PMid:10708408
20. Dey S, Pharm M, Kumar Pradhan P, Upadhayay UM, Patel C, Lad B. Method Devlopment and Validation of Simvastatin by UV Spectrophotometric Method. J Pharm Res [Internet]. 2012;5(12):5380-2. Available from: https://www.researchgate.net/publication/288567476
21. Chavhan V, Ghante M. Stability Indicating UV Spectrophotometric Method Development And Validation Of Simvastatin In Bulk And Tablet Dosage Form. Journal of Applied Pharmacy. 2014;235.
22. Dhole SM, Yeole MP. First derivative UV-spectrophotometric method for simultaneous determination of simvastatin and ezetimibe in tablet dosage form. Scholars Research Library Der Pharmacia Lettre [Internet]. 2015;7(3):124-8. Available from: www.scholarsresearchlibrary.com
23. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q2(R1): Validation of Analytical Procedures: Text and Methodology. Geneva: ICH; 2005.
24. de Andrade MC, de Souza PL, Teixeira HL. Validation of a UV-spectrophotometric analytical method for determining a drug substance by linear regression analysis. Braz J Pharm Sci. 2019;55:e17707.
25. Patel N, Patel B, Patel M. Development and validation of UV spectrophotometric method for quantitative estimation of pharmaceutical compounds. Int J Pharm Sci Res. 2013;4(6):2318-23.
26. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q2(R1): Validation of analytical procedures: text and methodology. Geneva: ICH; 2005.
27. Miller JN, Miller JC. Statistics and chemometrics for analytical chemistry. 6th ed. Harlow (UK): Pearson Education; 2010.
28. Ermer J, Miller JH. Method validation in pharmaceutical analysis: a guide to best practice. 2nd ed. Weinheim: Wiley-VCH; 2014. https://doi.org/10.1002/9783527672202
29. Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci. 2011;2(1):21 5. https://doi.org/10.4103/2229-5186.79345
30. Long GL, Winefordner JD. Limit of detection: A closer look at the IUPAC definition. Anal Chem. 1983;55(7):712A 724A. https://doi.org/10.1021/ac00258a001
31. Ermer J. Validation in pharmaceutical analysis. Part I: An integrated approach. J Pharm Biomed Anal. 2001;24(5 6):755 67. https://doi.org/10.1016/S0731-7085(00)00530-6 PMid:11248468
32. Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs-A review. J Pharm Anal. 2014;4(3):159 65. https://doi.org/10.1016/j.jpha.2013.09.003 PMid:29403878 PMCid:PMC5761119
Published
Abstract Display: 35 
PDF Downloads: 15 PDF Downloads: 5 How to Cite
Issue
Section
Copyright (c) 2026 Pooja Harkal , Pravin Wakte , Sachin Bhusari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.